Danaher Corporation (NYSE:DHR) Shares Sold by M&T Bank Corp

M&T Bank Corp decreased its position in Danaher Corporation (NYSE:DHR - Free Report) by 7.4% during the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 459,054 shares of the conglomerate's stock after selling 36,621 shares during the period. M&T Bank Corp owned about 0.06% of Danaher worth $94,106,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently made changes to their positions in DHR. Bank Pictet & Cie Europe AG raised its position in Danaher by 22.8% in the 4th quarter. Bank Pictet & Cie Europe AG now owns 192,731 shares of the conglomerate's stock worth $44,241,000 after buying an additional 35,730 shares during the last quarter. Proficio Capital Partners LLC raised its holdings in shares of Danaher by 28.0% during the 4th quarter. Proficio Capital Partners LLC now owns 2,566 shares of the conglomerate's stock worth $589,000 after acquiring an additional 562 shares in the last quarter. Banco Santander S.A. raised its holdings in shares of Danaher by 56.2% during the 4th quarter. Banco Santander S.A. now owns 8,757 shares of the conglomerate's stock worth $2,010,000 after acquiring an additional 3,151 shares in the last quarter. Rialto Wealth Management LLC purchased a new stake in Danaher during the 4th quarter valued at $34,000. Finally, Sound View Wealth Advisors Group LLC raised its holdings in Danaher by 3.1% during the 4th quarter. Sound View Wealth Advisors Group LLC now owns 1,739 shares of the conglomerate's stock valued at $399,000 after buying an additional 52 shares during the period. Institutional investors own 79.05% of the company's stock.

Analysts Set New Price Targets

A number of research firms have weighed in on DHR. Citigroup reiterated a "buy" rating on shares of Danaher in a research note on Monday, April 7th. HSBC lowered their price target on Danaher from $270.00 to $240.00 in a report on Friday, April 25th. Wolfe Research decreased their target price on Danaher from $275.00 to $220.00 and set an "outperform" rating for the company in a report on Monday, April 7th. Wall Street Zen raised Danaher from a "hold" rating to a "buy" rating in a report on Friday, June 27th. Finally, Robert W. Baird decreased their target price on Danaher from $231.00 to $225.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. Four research analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $248.00.

Danaher Price Performance

Shares of Danaher stock traded up $4.59 on Thursday, reaching $205.55. The company's stock had a trading volume of 3,021,398 shares, compared to its average volume of 3,500,356. The company has a market capitalization of $147.11 billion, a P/E ratio of 39.91, a PEG ratio of 2.82 and a beta of 0.77. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $281.70. The stock has a 50-day moving average price of $195.77 and a 200-day moving average price of $206.81. The company has a quick ratio of 1.05, a current ratio of 1.43 and a debt-to-equity ratio of 0.31.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, beating analysts' consensus estimates of $1.62 by $0.26. The business had revenue of $5.74 billion during the quarter, compared to analysts' expectations of $5.58 billion. Danaher had a return on equity of 10.80% and a net margin of 15.81%. Analysts expect that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be paid a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.62%. Danaher's dividend payout ratio is presently 24.85%.

Insider Buying and Selling

In other Danaher news, Chairman Steven M. Rales sold 1,250,000 shares of the business's stock in a transaction on Monday, May 12th. The stock was sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the transaction, the chairman owned 3,105,808 shares of the company's stock, valued at approximately $611,036,665.92. The trade was a 28.70% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Christopher Paul Riley sold 15,805 shares of the business's stock in a transaction on Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total value of $3,129,390.00. Following the transaction, the executive vice president directly owned 15,179 shares in the company, valued at $3,005,442. This trade represents a 51.01% decrease in their position. The disclosure for this sale can be found here. Insiders own 11.10% of the company's stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.